As a part of the analytical test process, a standard solution was prepared and injected into the chromatographic device six times. System acceptability factors such as tailing factor, theoretical plates, and percent RSD were assessed in order to find the best strategy.

Specificity tests are performed on the analytical solutions such as diluent solution, placebo solution, standard solution, and sample solutions to look for any interferences. The approach’s specificity was validated because blank and placebo had no effect on the standard. The chromatograms (Figure 4) demonstrated that, under ideal chromatographic circumstances, Methylparaben, Propylparaben, and Glycopyrrolate were eluted at retention times of 3.45 min, 8.1 min, and 6.1 min, respectively in standard solution, with a complete runtime of 15 minutes.

Glycopyrrolate, Methylparaben, and Propylparaben concentrations (X-axis) vs. peak areas (Y-axis) were plotted on a graph, and the correlation coefficient was calculated to determine the linearity. There were produced a number of solutions with concentrations between roughly 20% and 160% of the intended concentration. Glycopyrrolate linearity solutions of 4, 8, 16, 20, 24, and 32 µg/mL, methylparaben solutions of 35, 70, 140, 170, 210, and 290 µg/mL, and propylparaben solutions of 4, 8, 16, 20, 24 and 32 microgram/mL were prepared and injected into the UPLC in 2 µL portions.

Glycopyrrolate Oral Solution 1 mg/5mL was administered at aimed concentrations and evaluated using test methodologies to determine the accuracy of the test procedures. Six samples were processed in accordance with the analytical test protocol, added to a chromatographic system, and assessed. The test chromatogram is presented in (Figure 5) together with the average assay percent and RSD for glycopyrrolate, methylparaben, and propylparaben.

Drug products were used to test the accuracy of glycopyrrolate recovery by changing sample quantities in response to the spike level. According to the test technique, test samples of glycopyrrolate, methylparaben, and propylparaben were created at the target assay test concentration in triplicate at each level. They were then preceded into a UPLC system and evaluated. % Recovery was calculated for each preparation, resulting in mean percent recoveries for each level of roughly 30%, 100%, and 150%.

The detection and quantification limits for glycopyrrolate, methylparaben, and propylparaben were investigated. The detection and quantification limits were determined using the signal-to-noise ratio. A series of solutions comprising glycopyrrolate, methylparaben, and propylparaben were created and injected into the chromatographic apparatus in accordance with the analytical test technique. The results in a signal-to-noise ratio of about 3 were used to calculate the limit of detection. The quantity that results in a signal-to-noise ratio of around 10 was used to define the quantification limit.

Six samples of glycopyrrolate oral solution 1 mg/5mL were prepared in accordance with the test solution’s specifications and evaluated in accordance with the analytical test technique for various UPLCs, various columns, various scientists, and various days. Differing days saw different evaluations of the system appropriateness traits for both the UPLC system and columns. Calculations were made to determine the %RSD of glycopyrrolate, methylparaben, and propylparaben.

Solution Stability was established for standards and sample preparation. Solutions were made, and kept at 5 digress, and 25 degrees. These solutions were injected into the UPLC and evaluated initial and at three different intervals. Calculated the standard solution’s similarity factor and the % assay for test preparation against freshly prepared standards. The difference was calculated using the initial results.

Forced deterioration (FD) investigations were carried out to show the optimized method’s capability to indicate stability under diverse stress circumstances. Details on the pathways for degradation and the generation of degradation impurities have been presented. According to stability testing of new drug substances and products, stress testing performed with the inclusion of API and drug product can help in detecting potential degradation products, resulting in the formation of the product’s real-time stability (ICH guidelines). The conditions for quick stability testing are often easier than those for forced degradation. The Forced degradation assay on the material was run using the Glycopyrrolate reference standard. A PDA-UV detector verified the peak purity of the FD samples; refer to (Table 6) for findings.

Individually, 2 mL of 0.5 N hydrochloric acid were added to the sample solution and it was stressed for 30 minutes on the workbench. After a mentioned time, sample solutions were removed and kept on the benchtop to cool to room temperature. The solution was diluted to the mark of the volumetric flask with the diluent and then neutralized with 2 mL of 0.5N sodium hydroxide to obtain the final concentration.

After being individually stressed with 2 mL of 0.1 N sodium hydroxide and kept on the benchtop for 15 minutes at 60˚C, the sample solution was examined. After the mentioned time, sample solutions were removed and kept on the benchtop to cool to room temperature. The solution was prepared to the mark of the volumetric flask with the diluent and then neutralised with 2 mL of 0.1N hydrochloric acid to obtain the final concentration.

Two millilitres of 0.3 percent hydrogen peroxide were used to individually stress each sample solution, which was then kept at room temperature for an hour. Further made up to the volumetric flask up to mark with the diluent.

For 24 hours, the test solution was heated at 80 degrees Celsius. A 50 mL volumetric flask was filled to the mark with the diluent after the sample had been heated in order to obtain the final concentration.

The sample’s photolytic stability was examined by exposing the sample liquid to UV light directly for seven days. Samples were illuminated with 1.2 million lux hours and subjected to 200 -watt hours per square metre of exposure. Without any material loss, the exposed sample vial was quantitatively transferred to a 50 mL volumetric flask. The volume was then diluted with the diluent to get the final concentration.

Using the optimised and validated method in combination with the in-process bulk solution of 0.2 mg/mL, the assay for glycopyrrolate, methylparaben, and propylparaben was tested. The method’s use in estimating liquid oral formulations was demonstrated using the commercially available Glycopyrrolate Liquid Oral Solution 1 mg/5mL.

This UPLC application can be used to analyse pharmaceutical product formulations, drug substances, routine, and in-process samples, as well as the measurement of glycopyrrolate and preservatives. This technique is simple and cost effective for routine QC analysis.

This technique can be used to analyse pharmaceutical product formulations, drug substances, routine, and in-process samples, as well as the measurement of glycopyrrolate and preservatives.

Glycopyrrolate Oral Solution is carefully weighed at 5.8 g into a 50 mL volumetric flask. 30 mL of diluent should be shaken for one to two minutes before being diluted to volume. As final solutions, standard and sample solutions were added to the UPLC. Six injections of the test sample were made, and the average peak areas were calculated (refer to precision results).

The detector wavelength was optimised using the maximum wavelength of methylparaben, propylparaben, and glycopyrrolate. The spectra showed that Methylparaben, Propylparaben, and Glycopyrrolate could be detected most effectively at a wavelength of 222 nm.

Parabens (methylparaben, propylparaben), and Glycopyrrolate were separated using the waters Acquity BEH C18 150 mm × 2.1 mm, 1.7 µm column and it was selected for testing.

For detection under the aforementioned chromatographic conditions, a sample concentration of 20 µg/mL glycopyrrolate, 180 µg/mL methylparaben, and 20 µg/mL propylparaben with a 2 µL injection volume. The data were deemed sufficient after the linearity of glycopyrrolate, methylparaben, and propylparaben in this sample concentration was verified.

According to the literature, Methylparaben and Propylparaben are highly soluble in organic solvents like acetonitrile and methanol but only minimally soluble in water. Glycopyrrolate is also water-soluble. Based on this knowledge, the solvents Methanol, Acetonitrile, and water were tested. Both water and a mixture of organic solvents don’t affect the medication product’s stability. Hence A blend of water, acetonitrile, and methanol (60:30:10 v/v/v) is used to prepare the diluent. It was determined that the chromatographic peak pattern and shape were satisfactory in this diluent.

The temperature of the column was set to 40˚C based on the separation of glycopyrrolate, methylparaben, and propylparaben.

Table 1 displays the findings of the parameters for system suitability which were discovered to be within the acceptance criteria.

No interference was seen at the retention time of any of the primary analytes in the analysis. Refer to Table 2 for further information.

The detector response was verified to be within the proper range, according to Table 3.

According to Table 4, the six sample preparations’ relative standard deviations and the mean recoveries percent from 30% to 150% of the specification are fell within the allowed range.

Results for Accuracy (Recovery)

According to Table 5, the %RSD of glycopyrrolate, methylparaben, and propylparaben was discovered to be within the acceptance criteria.

%RSD-Percentage Relative standard deviation.

In order to compute the percent assay of parabens and active, a sample and standard solutions were studied for stability at 5˚C and 25˚C at various time intervals. The medicine and preservatives were shown to be reasonably stable at room and refrigerator temperatures because the % assay was found to acceptable range at 5 and 25 degrees. The stability of the medication product was examined under several circumstances for quality control (QC) of samples.